Febuxostat Prescription Medicines in the Philippines

FEBUDAY Febuxostat 40mg is used for the chronic management of hyperuricemia, a condition characterized by high levels of uric acid in the blood. This accumulation often leads to urate crystal deposition, which is the underlying cause of gout. The medication is recommended for adults when urate deposition has already occurred, including a history of gouty arthritis or the presence of tophi. By selectively inhibiting xanthine oxidase, it effectively decreases the production of uric acid, thereby maintaining serum uric acid levels below 6 mg/dL.

XURIC Febuxostat 40mg is used for the chronic management of hyperuricemia, a condition characterized by high levels of uric acid in the blood. This accumulation often leads to urate crystal deposition, which is the underlying cause of gout. The medication is recommended for adults when urate deposition has already occurred, including a history of gouty arthritis or the presence of tophi. By selectively inhibiting xanthine oxidase, it effectively decreases the production of uric acid, thereby maintaining serum uric acid levels below 6 mg/dL.

ATENURIX Febuxostat 80mg is used for the chronic management of high uric acid levels in the blood, a condition known as hyperuricemia, in individuals who have gout. This medication is specifically intended for people where urate deposits have already formed, which may include a history or current presence of tophi or gouty arthritis. It functions as a selective xanthine oxidase inhibitor, which works to reduce the overall production of uric acid in the body. The therapeutic goal is to lower and maintain blood uric acid below a certain level to prevent further complications.

AFIXOSTAT 80 Febuxostat 80mg is used for the chronic management of high uric acid levels in the blood, a condition known as hyperuricemia, in individuals who have gout. This medication is specifically intended for people where urate deposits have already formed, which may include a history or current presence of tophi or gouty arthritis. It functions as a selective xanthine oxidase inhibitor, which works to reduce the overall production of uric acid in the body. The therapeutic goal is to lower and maintain blood uric acid below a certain level to prevent further complications.

FEBUNOL-40 Febuxostat 40mg is used for the chronic management of hyperuricemia, a condition characterized by high levels of uric acid in the blood. This accumulation often leads to urate crystal deposition, which is the underlying cause of gout. The medication is recommended for adults when urate deposition has already occurred, including a history of gouty arthritis or the presence of tophi. By selectively inhibiting xanthine oxidase, it effectively decreases the production of uric acid, thereby maintaining serum uric acid levels below 6 mg/dL.

FEBUXEB 80 Febuxostat 80mg is used for the chronic management of high uric acid levels in the blood, a condition known as hyperuricemia, in individuals who have gout. This medication is specifically intended for people where urate deposits have already formed, which may include a history or current presence of tophi or gouty arthritis. It functions as a selective xanthine oxidase inhibitor, which works to reduce the overall production of uric acid in the body. The therapeutic goal is to lower and maintain blood uric acid below a certain level to prevent further complications.

SITIBAST-80 Febuxostat 80mg is used for the chronic management of high uric acid levels in the blood, a condition known as hyperuricemia, in individuals who have gout. This medication is specifically intended for people where urate deposits have already formed, which may include a history or current presence of tophi or gouty arthritis. It functions as a selective xanthine oxidase inhibitor, which works to reduce the overall production of uric acid in the body. The therapeutic goal is to lower and maintain blood uric acid below a certain level to prevent further complications.

FEBUNORM Febuxostat 40mg is used for the chronic management of hyperuricemia, a condition characterized by high levels of uric acid in the blood. This accumulation often leads to urate crystal deposition, which is the underlying cause of gout. The medication is recommended for adults when urate deposition has already occurred, including a history of gouty arthritis or the presence of tophi. By selectively inhibiting xanthine oxidase, it effectively decreases the production of uric acid, thereby maintaining serum uric acid levels below 6 mg/dL.

FEBUXORIN Febuxostat 40mg is used for the chronic management of hyperuricemia, a condition characterized by high levels of uric acid in the blood. This accumulation often leads to urate crystal deposition, which is the underlying cause of gout. The medication is recommended for adults when urate deposition has already occurred, including a history of gouty arthritis or the presence of tophi. By selectively inhibiting xanthine oxidase, it effectively decreases the production of uric acid, thereby maintaining serum uric acid levels below 6 mg/dL.